Amgen Europe B.v. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Amgen Europe B.v.

Patent Number:
Title:
Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or Agonist
Applicant:
Opposition Date:
Jul 26, 2023
Patent Number:
Title:
Liquid Pharmaceutical Composition
Applicant:
Opposition Date:
Dec 20, 2018

Want to track Amgen Europe B.v.?

Feel free to send us a message here and we will get back to you